Trials / Terminated
TerminatedNCT02209701
Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors
A Phase I Intensive Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors Who Receive Radiation Therapy
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to determine the steady-state pharmacokinetics and urinary excretion of porfiromycin and major metabolites in head and neck cancer and other cancer patients with solid tumors who receive radiation therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Porfiromycin |
Timeline
- Start date
- 1999-12-01
- Primary completion
- 2000-07-01
- First posted
- 2014-08-06
- Last updated
- 2014-08-06
Source: ClinicalTrials.gov record NCT02209701. Inclusion in this directory is not an endorsement.